PRO-Salus Usługi Medyczne I Laboratoryjnesp. z o.o.

Other human health activities not elsewhere classified

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2018-07-30
Share capital
5,000.00 PLN
Registered address
al. Bohaterów Warszawy 40/2d4, 70-342 Szczecin, Poland

Financials

Revenue history (in k)

Filing timeliness

No financial statement for 2021 – the filing deadline has passed. 2 of 2 financial statements were filed late (the longest delay 509 days for 2019).

  • 2021not filed
  • 202017/05/2022
  • 201908/03/2022
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2020.

Results vs industry

Revenue
This companyUSD 410.13kMedianUSD 91.87kAverageUSD 1.38m
Net profit
This companyUSD 116.54kMedianUSD 2.66kAverageUSD 145.77k
Operating costs
This companyUSD 262.31kMedianUSD 82.72kAverageUSD 1.18m
Assets
This companyUSD 243.01kMedianUSD 39.38kAverageUSD 949.95k

Ownership

OwnerSharesShare valueStake
Paweł Czerwińskiage 38
100$1,350.62100%

Manner of representation

In the case of a one-person management board, the member of the management board makes declarations on behalf of the company. In the case of a management board consisting of two or more persons, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.

Beneficial owners

Person

Bank accounts

Was a VAT taxpayer from 2018-10-03 to 2022-07-11.

Reason for removal: Art. 96 ust. 9a pkt 2 (VAT returns not filed for 3 consecutive months or a quarter)

Debt

No entries in the National Debtors Register (KRZ).

MSiG notices

Publication dateEvent
Apr 16, 2024Dissolution without liquidation opened
Mar 10, 2022Dissolution without liquidation opened

Public aid

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$1,282

Competitors

Change history

DateEvent
2022-08-09PKD change
2022-03-22PKD change
2018-07-30Entered in the register

FAQ

Last updated: 2026-10-07